Translate
Recent News
-
Symposium’23 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 -
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, . -
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici. -
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici. -
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo. -
Le CERIMED obtient la double certification ISO 9001:2015 et NF X50-900:2016 pour ses activités de prestation et d’innovation radiologiques et nucléaires pré-cliniques
Le Centre Européen de Recherche en Imagerie Médicale (CERIMED, UMS AMU CNRS 2012) a obtenu le 5 juin 2022 la double certification ISO 9001:2015 et NF-X50-900:2016 pour -
Symposium’21 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies” -
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration -
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility
Last Publications (10/448)
- Cortez, BN, Kuo, MJM, Jha, A, Patel, M, Carrasquillo, JA, Prodanov, T et al.. Correction: Case series: ATRX variants in four patients with metastatic pheochromocytoma. Front Endocrinol (Lausanne). 2025;16 :1736207. doi: 10.3389/fendo.2025.1736207. PubMed PMID:41323964 PubMed Central PMC12661546.
- Vourc’h, M, Boissier, E, Lakhal, K, Grosjean, S, Labaste, F, Robin, E et al.. Cost-utility of point-of-care viscoelastic hemostatic assays in the management of bleeding during cardiac surgery: a single-blinded prospective multicenter stepped wedge cluster randomized trial in French context. Anaesth Crit Care Pain Med. 2025; :101704. doi: 10.1016/j.accpm.2025.101704. PubMed PMID:41274376 .
- Oomens, JE, Vos, SJ, Maserejian, NN, Boada, M, Didic, M, Engelborghs, S et al.. Associations of lifestyle factors with amyloid pathology in persons without dementia. J Alzheimers Dis. 2025;108 (3):1043-1059. doi: 10.1177/13872877251379083. PubMed PMID:41234025 PubMed Central PMC12647378.
- Bobot, S, Cazauvieilh, V, Lefèvre, F, Solignac, J, Mecerli, S, Brunet, P et al.. [Treatment adherence and chronic kidney disease: Psychological aspects, contributing factors, and potential levers]. Nephrol Ther. 2025;21 (6):509-519. doi: 10.1684/ndt.2025.145. PubMed PMID:41164915 .
- Bentegeac, R, Florens, N, Maanaoui, M, Maisons, V, Lanot, A, Bobot, M et al.. ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training. Clin Kidney J. 2025;18 (10):sfaf308. doi: 10.1093/ckj/sfaf308. PubMed PMID:41133180 PubMed Central PMC12541372.
- Tolboom, N, Albert, NL, Braat, AJAT, Snijders, TJ, Tabouret, E, Taillandier, L et al.. From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials. J Nucl Med. 2025; :. doi: 10.2967/jnumed.125.270820. PubMed PMID:41101976 .
- Agripnidis, T, Ayobi, A, Quenet, S, Chaibi, Y, Avare, C, Jacquier, A et al.. Performance of an artificial intelligence tool for multi-step acute stroke imaging: A multicenter diagnostic study. Eur J Radiol Open. 2025;15 :100678. doi: 10.1016/j.ejro.2025.100678. PubMed PMID:40933241 PubMed Central PMC12419105.
- Gargiulo, M, Di-Rocco, C, Panneau, J, Nguyen, J, Marx, T, Haumont, R et al.. Additional In Vivo Study of Arterial Embolization with a Novel Agar-Based Embolic Agent: Feasibility and Efficacy of New-Size Implants for Improved Microcatheter Injectability. Cardiovasc Intervent Radiol. 2025; :. doi: 10.1007/s00270-025-04193-6. PubMed PMID:40925978 .
- Vantyghem, MC, Mirallié, E, Al-Salameh, A, Aubert, S, Barraud, S, Baud, G et al.. French expert consensus statement on diagnosis and management of primary hyperparathyroidism. Ann Endocrinol (Paris). 2025;86 (5):102449. doi: 10.1016/j.ando.2025.102449. PubMed PMID:40889554 .
- Dumortier, J, Chopinet, S, L’Huillier, R, Puia-Negulescu, S, Adham, M, Milot, L et al.. Adult Left Liver Transplantation With Mesocaval Shunt With Porto-Mesenteric Disconnection: Long-Term Outcome. Clin Transplant. 2025;39 (9):e70292. doi: 10.1111/ctr.70292. PubMed PMID:40875200 PubMed Central PMC12393188.
Dernières Publications (10/448)
- Cortez, BN, Kuo, MJM, Jha, A, Patel, M, Carrasquillo, JA, Prodanov, T et al.. Correction: Case series: ATRX variants in four patients with metastatic pheochromocytoma. Front Endocrinol (Lausanne). 2025;16 :1736207. doi: 10.3389/fendo.2025.1736207. PubMed PMID:41323964 PubMed Central PMC12661546.
- Vourc’h, M, Boissier, E, Lakhal, K, Grosjean, S, Labaste, F, Robin, E et al.. Cost-utility of point-of-care viscoelastic hemostatic assays in the management of bleeding during cardiac surgery: a single-blinded prospective multicenter stepped wedge cluster randomized trial in French context. Anaesth Crit Care Pain Med. 2025; :101704. doi: 10.1016/j.accpm.2025.101704. PubMed PMID:41274376 .
- Oomens, JE, Vos, SJ, Maserejian, NN, Boada, M, Didic, M, Engelborghs, S et al.. Associations of lifestyle factors with amyloid pathology in persons without dementia. J Alzheimers Dis. 2025;108 (3):1043-1059. doi: 10.1177/13872877251379083. PubMed PMID:41234025 PubMed Central PMC12647378.
- Bobot, S, Cazauvieilh, V, Lefèvre, F, Solignac, J, Mecerli, S, Brunet, P et al.. [Treatment adherence and chronic kidney disease: Psychological aspects, contributing factors, and potential levers]. Nephrol Ther. 2025;21 (6):509-519. doi: 10.1684/ndt.2025.145. PubMed PMID:41164915 .
- Bentegeac, R, Florens, N, Maanaoui, M, Maisons, V, Lanot, A, Bobot, M et al.. ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training. Clin Kidney J. 2025;18 (10):sfaf308. doi: 10.1093/ckj/sfaf308. PubMed PMID:41133180 PubMed Central PMC12541372.
- Tolboom, N, Albert, NL, Braat, AJAT, Snijders, TJ, Tabouret, E, Taillandier, L et al.. From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials. J Nucl Med. 2025; :. doi: 10.2967/jnumed.125.270820. PubMed PMID:41101976 .
- Agripnidis, T, Ayobi, A, Quenet, S, Chaibi, Y, Avare, C, Jacquier, A et al.. Performance of an artificial intelligence tool for multi-step acute stroke imaging: A multicenter diagnostic study. Eur J Radiol Open. 2025;15 :100678. doi: 10.1016/j.ejro.2025.100678. PubMed PMID:40933241 PubMed Central PMC12419105.
- Gargiulo, M, Di-Rocco, C, Panneau, J, Nguyen, J, Marx, T, Haumont, R et al.. Additional In Vivo Study of Arterial Embolization with a Novel Agar-Based Embolic Agent: Feasibility and Efficacy of New-Size Implants for Improved Microcatheter Injectability. Cardiovasc Intervent Radiol. 2025; :. doi: 10.1007/s00270-025-04193-6. PubMed PMID:40925978 .
- Vantyghem, MC, Mirallié, E, Al-Salameh, A, Aubert, S, Barraud, S, Baud, G et al.. French expert consensus statement on diagnosis and management of primary hyperparathyroidism. Ann Endocrinol (Paris). 2025;86 (5):102449. doi: 10.1016/j.ando.2025.102449. PubMed PMID:40889554 .
- Dumortier, J, Chopinet, S, L’Huillier, R, Puia-Negulescu, S, Adham, M, Milot, L et al.. Adult Left Liver Transplantation With Mesocaval Shunt With Porto-Mesenteric Disconnection: Long-Term Outcome. Clin Transplant. 2025;39 (9):e70292. doi: 10.1111/ctr.70292. PubMed PMID:40875200 PubMed Central PMC12393188.